Table of Contents
ISRN Preventive Medicine
Volume 2013 (2013), Article ID 295783, 3 pages
Research Article

Surgical Site Infection Complicating Breast Cancer Surgery in Kuwait

1Infection Control Department, Kuwait Cancer Control Center and Infection Control Directorate, Ministry of Health, Kuwait
2Department of Microbiology, High Institute of Public Health, Alexandria University, Egypt
3Infection Control Directorate, Ministry of Health, Kuwait

Received 10 October 2012; Accepted 15 November 2012

Academic Editors: L. C. Borris, C. Hughes, and D. Ziad

Copyright © 2013 Abeer A. Omar and Haifaa H. Al-Mousa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background and Objectives. Surgical site infection (SSI) is the most common postoperative complication associated with breast cancer surgery. The present investigation aimed to determine the SSI rate after breast cancer surgeries and the causative microorganisms. Patients and Methods. All patients who underwent breast surgery in Kuwait Cancer Control Center as a treatment for breast cancer from January 2009–December 2010 were prospectively followed for the development of SSI. Indirect detection was used to identify SSIs through medical record to review and discussion with the treating surgeons. Results. The number of operations was 438. Females represented 434 (99.1%) cases while males constituted only 4 (0.9%) cases. SSIs were diagnosed after 10 operations, all for female cases. Most of the SSIs (8 cases; 80%) were detected after patients were discharged, during outpatient followup. Out of those 5/8; (62.5%) were readmitted for management of SSI. Nine patients (90%) received systemic antibiotic therapy for management of their wound infection. The SSI rate was 2.3%. The main causative organism was Staphylococcus aureus (S. aureus) which was responsible for 40% of infections. Gram negative bacteria were isolated from 40% of the cases. Conclusion. SSI is an important complication following breast cancer surgery. Microbiological diagnosis is an essential tool for proper management of such patients.